The HIgh-fidelity Hydraulic couPling Upper-arm Cuff Assessment of Limits, Safety, and Effectiveness (HIPULSE) Trial
HIPULSE
1 other identifier
observational
205
2 countries
4
Brief Summary
The purpose of this study is to compare measurements of blood pressure (BP) and fluid responsiveness between the Philips AMC and invasive radial arterial line in surgical patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2025
Shorter than P25 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 19, 2025
CompletedFirst Posted
Study publicly available on registry
March 26, 2025
CompletedStudy Start
First participant enrolled
October 2, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2026
CompletedFebruary 27, 2026
February 1, 2026
4 months
March 19, 2025
February 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Primary Endpoints
The comparison of systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP) between the Philips AMC and radial arterial line.
Approximately 8 months accrual and follow-up evaluation period.
Study Arms (1)
Philips AMC Cuff
This is a non-randomized, single arm, self-controlled observational study. The Philips AMC cuff will be tested on all enrolled participants.
Interventions
Investigational, non-invasive upper arm cuff
Eligibility Criteria
Up to 205 non-cardiac surgical or Intensive Care Unit (ICU) patients being monitored with a radial arterial line will be enrolled over approximately 8 months accrual and follow-up evaluation period.
You may qualify if:
- Adults aged 18 years and older
- Indication for NIBP cuff
- Indication for a radial arterial line
- Subject or legal authorized representative is able to understand and speak the local language (also Spanish for US sites) to provide voluntary written informed consent prior to study procedures
- The following stratification criteria must be met across the study sites and hence targeted enrollment may be required:
- Age of every patient 18+; at least 30% \> 65 years, 30% ≤ 65 years
- At least 30% male, 30% female
- Minimum number of subjects needed to test each size cuff (per ISO81060-2:2018/AMD2:2024, based on limb circumference range):
- Adult Small (19-27 cm) = 165\*\[8/(2\*24)\] = 28
- Adult (25-34 cm) = 165\*\[9/(2\*24)\] = 31
- Adult Large Short (30-40 cm with severely conical arm) = 165\*\[10/(2\*24)\] = 35
- Adult Large (32-43 cm) = 165\*\[11/(2\*24)\] = 38
- At least 40% of the subjects within each cuff size shall have a limb circumference that lies within the upper half of the specified range of use of the cuff
- At least 40% of the subjects within each cuff size shall have a limb circumference within the lower half of the specified range of use of the cuff
- At least 10% SBP measurements ≤ 100 mmHg
- +3 more criteria
You may not qualify if:
- Emergency surgery
- Surgeries in which both arms are tucked
- Inability to place the Philips AMC appropriately due to subject anatomy or condition
- Known pregnancy or lactating women (self-report)
- Patients treated with an intra-aortic balloon pump
- Aortic and mitral regurgitation (\> 2nd degree), if known
- Measurements taken in the lateral position
- Pressure of the arterial line system, when tested at 100 mmHg with the VeriCal device, exceeds the +/- 2 mmHg threshold
- Currently participating in an investigational drug or another device study that clinically interferes with the study endpoints
- Upper arm circumference \< 19 cm or \> 43 cm
- BMI \> 45
- If the average of 3 baseline NIBP lateral difference measurements for SBP is \> 15 mmHg or for DBP is \> 10 mmHg
- At the PI's discretion, subject does not qualify to participate in the study for any reasons that are not mentioned above
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
Duke University Health System
Durham, North Carolina, 27710, United States
Wake Forest Baptist Medical Center
Winston-Salem, North Carolina, 27157, United States
LMU Klinikum , Campus Großhadern
München, Bavaria, 81377, Germany
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 19, 2025
First Posted
March 26, 2025
Study Start
October 2, 2025
Primary Completion
February 1, 2026
Study Completion
February 1, 2026
Last Updated
February 27, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share